1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pheochromocytoma Global Clinical Trials Review, H1, 2014

Pheochromocytoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Pheochromocytoma Global Clinical Trials Review, H1, 2014" provides data on the Pheochromocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pheochromocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pheochromocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pheochromocytoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pheochromocytoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Pheochromocytoma to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Pheochromocytoma 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Pheochromocytoma Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Pheochromocytoma 28
Nov 25, 2013: Progenics Pharmaceuticals Relaunching Registrational Trial of Azedra to Treat Pheochromocytomas 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Progenics Pharmaceuticals, Inc. 29
Clinical Trial Overview of Progenics Pharmaceuticals, Inc. 29
Nektar Therapeutics 30
Clinical Trial Overview of Nektar Therapeutics 30
Jubilant Life Sciences Limited 31
Clinical Trial Overview of Jubilant Life Sciences Limited 31
Insys Therapeutics, Inc. 32
Clinical Trial Overview of Insys Therapeutics, Inc. 32
GE Healthcare 33
Clinical Trial Overview of GE Healthcare 33
Clinical Trial Overview of Top Institutes / Government 34
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
University of California, San Francisco 35
Clinical Trial Overview of University of California, San Francisco 35
Seoul National University Hospital 36
Clinical Trial Overview of Seoul National University Hospital 36
Assistance Publique Hopitaux De Marseille 37
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 37
Cincinnati Children's Hospital Medical Center 38
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 38
European Organization for Research and Treatment of Cancer 39
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 39
University Medical Center Groningen 40
Clinical Trial Overview of University Medical Center Groningen 40
University of Southern California 41
Clinical Trial Overview of University of Southern California 41
Rouen University Hospital 42
Clinical Trial Overview of Rouen University Hospital 42
University Hospital, Angers 43
Clinical Trial Overview of University Hospital, Angers 43
Five Key Clinical Profiles 44
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 82

List of Tables
Pheochromocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Pheochromocytoma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Pheochromocytoma Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Progenics Pharmaceuticals, Inc., 2014* 29
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nektar Therapeutics, 2014* 30
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jubilant Life Sciences Limited, 2014* 31
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 32
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2014* 33
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 34
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 35
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 36
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2014* 37
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014* 38
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 39
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014* 40
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2014* 41
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2014* 42
Pheochromocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014* 43

List of Figures
Pheochromocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Pheochromocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Pheochromocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Pheochromocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Pheochromocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Pheochromocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pheochromocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Pheochromocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Pheochromocytoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Pheochromocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Pheochromocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Pheochromocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Pheochromocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Pheochromocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Pheochromocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Pheochromocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Pheochromocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Pheochromocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.